Noritaka Wakui Selected Research

Sonazoid

1/2019	Flash Imaging Used in the Post-vascular Phase of Contrast-Enhanced Ultrasonography is Useful for Assessing the Progression in Patients with Hepatitis C Virus-Related Liver Disease.
1/2019	A New Method to Quantify Concentration of Microbubbles in Attenuating Media Using Bubble Destruction Curve Analysis of the Contrast-Enhanced Ultrasound.
10/2015	Effect of obstructive jaundice on hepatic hemodynamics: use of Sonazoid-enhanced ultrasonography in a prospective study of the blood flow balance between the hepatic portal vein and hepatic artery.
4/2015	Spontaneous complete necrosis of hepatocellular carcinoma: A case report and review of the literature.
7/2013	Arrival time parametric imaging of the hemodynamic balance changes between the hepatic artery and the portal vein during deep inspiration, using Sonazoid-enhanced ultrasonography: A case of Budd-Chiari syndrome.
6/2013	Arrival time parametric imaging using Sonazoid-enhanced ultrasonography is useful for the detection of spoke-wheel patterns of focal nodular hyperplasia smaller than 3 cm.
3/2013	Visualization of segmental arterialization with arrival time parametric imaging using Sonazoid-enhanced ultrasonography in portal vein thrombosis: A case report.
3/2012	Usefulness of arrival time parametric imaging in evaluating the degree of liver disease progression in chronic hepatitis C infection.
9/2011	Diagnosis of hepatic hemangioma by parametric imaging using sonazoid-enhanced US.
5/2010	Evaluation of local recurrence after treatment for hepatocellular carcinoma by contrast-enhanced ultrasonography using Sonazoid: comparison with dynamic computed tomography.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Noritaka Wakui Research Topics

Disease

20	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 11/2008
14	Neoplasms (Cancer) 01/2022 - 11/2008
10	Liver Cirrhosis (Hepatic Cirrhosis) 04/2019 - 11/2010
4	Thrombosis (Thrombus) 01/2022 - 03/2013
4	Chronic Hepatitis C 04/2012 - 03/2003
3	Liver Diseases (Liver Disease) 01/2019 - 03/2012
3	Jaundice (Icterus) 10/2015 - 02/2013
3	Infections 02/2015 - 03/2003
2	Fibrosis (Cirrhosis) 01/2019 - 11/2010
2	Hemangioma (Angioma) 09/2011 - 04/2010
1	Breast Neoplasms (Breast Cancer) 01/2020
1	Insulin Resistance 01/2017
1	Non-alcoholic Fatty Liver Disease 01/2017
1	Obstructive Jaundice (Cholestatic Jaundice) 10/2015
1	Necrosis 04/2015
1	Alcoholism (Alcohol Abuse) 02/2015
1	Cholangitis 01/2014
1	Fever (Fevers) 11/2013
1	Budd-Chiari Syndrome (Budd Chiari Syndrome) 07/2013
1	Focal Nodular Hyperplasia 06/2013
1	Hepatitis C 10/2011
1	Neoplasm Metastasis (Metastasis) 10/2011
1	Myocardial Infarction 10/2011
1	Gastrointestinal Hemorrhage (Hematochezia) 10/2011
1	Alcoholic Liver Cirrhosis (Alcoholic Cirrhosis) 07/2011
1	Ascites 11/2010
1	Carcinoma (Carcinomatosis) 11/2009
1	Ulcerative Colitis 08/2005
1	Alcoholic Liver Diseases (Alcoholic Liver Disease) 08/2004

Drug/Important Bio-Agent (IBA)

12	SonazoidIBA 01/2019 - 04/2010
5	Sorafenib (BAY 43-9006)FDA Link 04/2019 - 10/2011
4	Contrast MediaIBA 01/2019 - 09/2011
3	InterferonsIBA 04/2019 - 01/2006
2	Fluorouracil (Carac)FDA LinkGeneric 01/2020 - 11/2010
2	Proteins (Proteins, Gene)FDA Link 01/2020 - 11/2009
2	CytokinesIBA 02/2014 - 03/2003
1	lenvatinibIBA 01/2022
1	Pharmaceutical PreparationsIBA 01/2020
1	Oxidoreductases (Dehydrogenase)IBA 01/2020
1	EnzymesIBA 01/2020
1	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 01/2020
1	ARQ 197IBA 01/2020
1	1,4-dihydropyridine (dihydropyridine)IBA 01/2020
1	Interleukin-4 (Interleukin 4)IBA 04/2019
1	Aconitic Acid (Aconitate)IBA 01/2017
1	Nonesterified Fatty Acids (NEFA)IBA 01/2017
1	Glucose (Dextrose)FDA LinkGeneric 01/2017
1	Insulin (Novolin)FDA Link 01/2017
1	IsotopesIBA 01/2017
1	LipidsIBA 01/2017
1	Biomarkers (Surrogate Marker)IBA 01/2017
1	Citric Acid (Citrate)FDA LinkGeneric 01/2017
1	AdiponectinIBA 01/2017
1	Capsules (Microcapsules)IBA 04/2015
1	Lamivudine (Epivir)FDA Link 02/2015
1	Fas Ligand Protein (Fas Ligand)IBA 02/2014
1	fas Receptor (CD95 Antigen)IBA 02/2014
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2014
1	TNF-Related Apoptosis-Inducing LigandIBA 02/2014
1	Anti-Bacterial Agents (Antibiotics)IBA 11/2013
1	Ursodeoxycholic Acid (Urso)FDA LinkGeneric 02/2013
1	Amino Acids FDA Link 04/2012
1	perfluorobutane (AI 700)IBA 03/2012
1	Warfarin (Coumadin)FDA LinkGeneric 10/2011
1	Transaminases (Aminotransferases)IBA 11/2010
1	Serum AlbuminIBA 11/2010
1	Ethanol (Ethyl Alcohol)IBA 03/2010
1	Vitamin K FDA Link 11/2009
1	Ribavirin (Virazole)FDA LinkGeneric 01/2006
1	SHU 508 (Levovist)IBA 08/2004
1	LactoferrinIBA 03/2003

Therapy/Procedure

8	Therapeutics 01/2020 - 01/2009
6	Radiofrequency Ablation 12/2012 - 11/2008
5	Drug Therapy (Chemotherapy) 04/2015 - 11/2010
3	Combination Drug Therapy (Combination Chemotherapy) 06/2013 - 11/2010
3	Electrodes (Electrode) 03/2010 - 01/2009
2	Aftercare (After-Treatment) 04/2019 - 05/2010
2	Microbubbles 01/2019 - 01/2019
1	Stents 01/2014
1	Oral Administration 02/2013
1	Intravenous Injections 04/2010
1	Kidney Transplantation 08/2005